Egger, Martin; Seiler, Roland (2023). Which Patients To Consider for Bladder Preservation After a Complete Response to Neoadjuvant Chemotherapy. European urology focus, 9(2), pp. 229-231. Elsevier 10.1016/j.euf.2023.01.023
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
1-s2.0-S2405456923000354-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (166kB) |
The decision on which patients with muscle-invasive bladder cancer to consider for bladder preservation remains controversial. New promising technologies and biomarkers may allow to precise selection of patients for bladder preservation in the future. Currently, bladder preservation should only be considered in highly selected cases and in the setting of clinical trials.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Urologie 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Urologie |
UniBE Contributor: |
Seiler-Blarer, Roland |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2405-4569 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
13 Feb 2023 13:17 |
Last Modified: |
14 Apr 2023 14:16 |
Publisher DOI: |
10.1016/j.euf.2023.01.023 |
PubMed ID: |
36775715 |
BORIS DOI: |
10.48350/178711 |
URI: |
https://boris.unibe.ch/id/eprint/178711 |
Actions (login required)
 |
Edit item |